Bladder cancer patients over 70 less likely to get curative treatment

April 17, 2013

(Medical Xpress)—Older bladder cancer patients are less likely than younger patients to receive treatments intended to cure their disease such as surgery to remove the bladder or radiotherapy. But this difference cannot be fully explained by age, according to new research by scientists published in the British Journal of Cancer.

Researchers, funded by Yorkshire at the University of Sheffield, looked at the records of around 3,300 bladder cancer patients diagnosed in Sheffield between 1994 and 2009. They wanted to investigate how age, type of bladder cancer and treatment affected the chances of surviving the disease2.

They found that 52 per cent of patients under 60 had potentially curative treatments such as surgery or radiotherapy, compared with 34 per cent of patients in their 70s and only 12 per cent of patients over 80.

And older patients over 70 were more likely to die of their bladder cancer than younger patients.

The researchers believe that the higher number of deaths in those over 70 is because these patients had a higher proportion of more aggressive tumours and were less likely to receive radical treatments such as or surgery to remove the bladder and nearby organs.

Mr James Catto, study author and consultant urological surgeon at the University of Sheffield, said: "Even though it appears that older patients are more likely to have aggressive tumours, our findings suggest that not enough older patients are being offered treatments that could increase their chance of survival.

"What's very worrying is this conservative approach to treating older patients appears to be affecting the life expectancy of this group, something that doctors must work hard to combat."

Dr Kathryn Scott, head of research funding at Yorkshire Cancer Research, said: "This research shows that the age of bladder in Sheffield greatly affects how they are treated. This has a considerable effect on in elderly patients and Yorkshire, along with the rest of the UK, is going to have to change to address this striking difference."

Sarah Woolnough, executive director of policy and information at Cancer Research UK, said: "This study shows the older the patients are the less likely they are to be offered the kind of treatments that could cure their cancer.

"These decisions are never easy and need to be balanced with quality of life but it's vital for patients of all ages to be given the option of a possible cure when it is still feasible."

Explore further: Adding chemo to radiotherapy halves risk of deadly bladder cancer returning

More information: Noon, A. et al. (2013). Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients British Journal of Cancer DOI: 10.1038/bjc.2013.106

Related Stories

Adding chemo to radiotherapy halves risk of deadly bladder cancer returning

April 23, 2012
(Phys.org) -- Bladder cancer patients given low doses of chemotherapy combined with radiotherapy were nearly 50 per cent less likely to relapse with the most lethal form of the disease compared to patients given radiotherapy ...

Multi-tasking imatinib boosts radiotherapy for bladder tumours

March 4, 2013
Cancer drug imatinib (Glivec) could boost radiotherapy treatment to destroy bladder cancer that has spread to the bladder wall, reveals research published in Cancer Research.

Chemo - radiation best for bladder cancer, study finds

April 19, 2012
(HealthDay) -- The addition of two well-tolerated chemotherapy drugs to radiation therapy led to significantly longer survival rates among patients with muscle-invasive bladder cancer.

Elderly breast cancer patients less likely to get surgery

June 17, 2011
(PhysOrg.com) -- University of Manchester researchers, working with colleagues in York, Leeds and Hull, looked at the records of more than 23,000 women with breast cancer diagnosed in the West Midlands, Yorkshire and North ...

Recommended for you

Many pelvic tumors in women may have common origin—fallopian tubes

October 17, 2017
Most—and possibly all—ovarian cancers start, not in ovaries, but instead in the fallopian tubes attached to them.

Researchers find novel mechanism of resistance to anti-cancer drugs

October 17, 2017
The targeted anti-cancer therapies cetuximab and panitumumab are mainstays of treatment for advanced colorectal cancer, the second leading cause of cancer-related deaths in the United States. However, many patients have tumors ...

Using artificial intelligence to improve early breast cancer detection

October 17, 2017
Every year 40,000 women die from breast cancer in the U.S. alone. When cancers are found early, they can often be cured. Mammograms are the best test available, but they're still imperfect and often result in false positive ...

Biology of childhood brain tumor subtypes offers clues to precision treatments

October 17, 2017
Researchers investigating pediatric low-grade gliomas (PLGG), the most common type of brain tumor in children, have discovered key biological differences in how mutated genes combine with other genes to drive this childhood ...

New assay may boost targeted treatment of non-Hodgkin lymphoma

October 17, 2017
Diffuse large B-cell lymphoma (DLBCL) is an aggressive cancer and the most frequently diagnosed non-Hodgkin lymphoma worldwide (nearly 40% of cases). Recent advancements indicate that both the prognosis and choice of treatment ...

Bolstering fat cells offers potential new leukemia treatment

October 16, 2017
Killing cancer cells indirectly by powering up fat cells in the bone marrow could help acute myeloid leukemia patients, according to a new study from McMaster University.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.